Vote NO Pfizer offer, page-208

Unless the T/O bid is increased, how are they going to convince the share holders the benefit of accepting just 3c more than before the T/O bid happened? It's not like most of the top 20 holders have an average price of 4c (the big volumes were traded in the 10c range a few time after the pps dropped to 4-6c) and even if they did, they will only be getting 3c more than how much the market valued RAP before the T/O bid and now we have a big pharmacy and excellent global PR from this T/O bid.....